NYSE$HIMS
Hims & Hers Health Inc · Q4 2021 earnings
Q4 2021 earnings · · Investor relations
Briefing
Reported financial results for the fourth quarter and full year ended December 31, 2021, surpassing revenue and Adjusted EBITDA expectations.
Hims & Hers Health, Inc. reported a strong Q4 2021 with revenue reaching $84.7 million, a 104% increase year-over-year, and ending member subscriptions growing 95% year-over-year to 609,000. The company exceeded its revenue and Adjusted EBITDA guidance for both Q4 2021 and the full year 2021.
- Q4 2021 revenue increased 104% year-over-year to $84.7 million.
- Q4 2021 ending member subscriptions grew 95% year-over-year to 609,000.
- Launched Hims & Hers mobile platform on the iOS app store.
- Announced additional strategic national omnichannel retail collaborations with Amazon, CVS, GNC, Walgreens, and Walmart.
Headline financials
Revenue & EPS history
Hims & Hers · Revenue · Quarterly
$84.7M
Revenue by segment
Hims & Hers · $84.7M total across 2 segments · Q4 2021
- Online Revenue$78.3M+95.3%92.5%
- Wholesale Revenue$6.39M+364.5%7.5%
Forward guidance
For Q1 2022, Hims & Hers expects revenue in the range of $90 million to $93 million and Adjusted EBITDA in the range of $(12) million to $(10) million. For full year 2022, the company expects revenue in the range of $365 million to $380 million and Adjusted EBITDA in the range of $(30) million to $(20) million.
Tailwinds
- Revenue to be in the range of $90 million to $93 million for Q1 2022.
- Adjusted EBITDA to be in the range of $(12) million to $(10) million for Q1 2022.
- Revenue to be in the range of $365 million to $380 million for full year 2022.
- Adjusted EBITDA to be in the range of $(30) million to $(20) million for full year 2022.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 19 quarterly earnings reports · overlaid with Q4 2021
+2.5%
Avg return
Earnings day
+3.8%
Avg return
5 days after
+11.7%
Avg return
30 days after
50%
13 / 26 earnings
Positive
+41.1%
Q4 2023
Best reaction
-22.3%
Q4 2024
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +3.0% | -11.4% | -1.8% | |
| Q4 2025 | -2.8% | -6.4% | +34.5% | |
| Q3 2025 | -3.6% | -7.6% | -9.8% | |
| Q1 2025 | +18.5% | +24.1% | +26.0% | |
| Q4 2024 | -22.3% | -12.1% | -37.8% | |
| Q3 2024 | +1.4% | +15.0% | +66.6% | |
| Q2 2024 | -4.0% | -9.2% | -16.9% | |
| Q1 2024 | +9.7% | +9.1% | +93.2% | |
| Q4 2023 | +41.1% | +37.8% | +65.3% | |
| Q3 2023 | +7.6% | +5.1% | +37.3% | |
| Q2 2023 | -8.7% | -11.7% | -15.2% | |
| Q1 2023 | -11.5% | -10.2% | -23.9% | |
| Q4 2022 | +15.4% | +6.0% | +2.7% | |
| Q3 2022 | +30.1% | +37.2% | +64.7% | |
| Q2 2022 | -3.4% | +9.2% | -0.6% | |
| Q1 2022 | -13.0% | -13.5% | +5.3% | |
| Q4 2021 | +8.0% | +20.5% | +19.8% | |
| Q3 2021 | -7.0% | -1.3% | -26.3% | |
| Q2 2021 | +7.0% | -4.7% | +11.1% | |
| Q1 2021 | +13.7% | +44.9% | +33.1% | |
| Q2 2020 | -8.4% | -7.2% | -21.9% | |
| Q4 2020 | -7.5% | -15.4% | -21.3% | |
| Q3 2020 | +0.1% | +0.0% | +17.5% | |
| Q1 2020 | -0.7% | -0.5% | +0.1% | |
| Q4 2019 | +1.4% | +2.1% | +2.2% | |
| Q3 2019 | +0.0% | +0.3% | -0.6% | |
| Q2 2019 | — | — | — | |
| Q1 2019 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro